Category Archives: Treatment

Eric Lefkofsky’s Quest To End Cancer Now

Eric Lefkofsky is a lawyer and entrepreneur who has focused much of his career on advances in technology. He graduated with honors from the University of Michigan in 1991 and earned his Juris Doctor Degree from the University of Michigan School of Law.

In 2006, Lefkofsky founded Media Bank to serve the technology needs of advertising buyers. In 2012, a merger was created between Media Bank and Donovan Data Systems. This 1.5-billion-dollar deal established Lefkofsky as an outstanding entrepreneur.

Eric Lefkofsky has participated in Community projects such as serving on the Board of Directors of the Children’s Memorial Hospital, the Art Institute of Chicago, and the Museum of Science and Industry. He is involved in philanthropic endeavors, including the Lefkofsky Foundation he and his wife founded to support worthy organizations all over the world.

Lefkofsky’s entrance into the arena of medicine came when a loved one was diagnosed with cancer. Realizing that the healthcare system did not have the technological framework to successfully blend genomic and clinical data, Lefkofsky co-founded Tempus late in 2015 to construct an extensive database of genomic and clinical data to make cancer treatment more precise.

The certified lab for Tempus in Chicago gathers and analyzes therapeutic and molecular data for clinical associates such as well-known educational medical centers, network hospitals, and oncology centers and physicians. These databases are constantly expanding.

In a June 2017 blog post, Eric Lefkofsky shares his enthusiasm for the quest to eliminate cancer. He explains that the expense of genetic sequencing has dramatically decreased since 2000, making it finally affordable.

Another factor in finding a cancer cure is the increased knowledge of how to channel a person’s own immune system as an ally in the battle against cancer. Lefkofsky states that one of the great challenges of this generation will be to formulate a data-based method of matching an individual’s genetic composition with their optimal cancer treatment. He believes the time is now!

To Read More Click Here

How David Samadi is Helping Prostate Cancer Patients

When Mitt Romney, a prominent politician in the United States discovered that he had an abnormal mass in his prostate glands, he decided to seek medical attention from one of the leading medical facilities. At first, he did not know how the whole process will be, but the doctor discovered that the politician was suffering from prostate cancer, a dangerous form of cancer that is very common to men who are over forty years of age. At the time the doctor was making this discovery, Mitt Romney was already sixty nine years of age, and this is why he was at a higher risk of getting the disease.

Romney is not the only man in the country who is dealing with prostate cancer. Unfortunately, there are millions of men in the society who are battling the disease in most parts of the country. According to a recent study, this number might even go up in the next two years. Many men, especially those who have reached the age of forty risk getting the disease, and this is why they should seek medical attention early so that the medical condition can be cured. David Samadi, a leading medical expert who is based in New York City, has been a leading expert when it comes to cancer treatment.

According to David Samadi, men who are past the age of forty should be treated immediately they suspect that they are suffering from cancer. The medical condition can affect anyone, even the young men who have not yet attained the age of forty. The people who are treated early can have a new chance of life because they can be cured and declared cancer free. In the course of his career in medicine, David Samadi has been instrumental in the diagnosis and treatment of prostate cancer patients in the United States and other parts of the world.

David Samadi understands some of the most effective cancer therapies that can be used on patients, and this is why he has made sure that ninety percent of all his patients are declared cancer free by the time they are completing their cancer treatment. There are several treatment options that are used by Samadi and the team in New York City. Some of the patients are cured using prostate surgery while others have to undergo chemotherapy and radiotherapy treatments. People who are discovered to have the illness when it is still in the early stages have better chances of getting better.

Read More:


Eric Lefkofsky Is Doing Great Things

Cancer is one of the hardest-hitting diseases in our modern society. Even though doctors haven’t conquered cancer thus far, it’s reasonable to say that in the future, the medical community will have mitigated the prevalence and lethality of cancer, just as modern medicine has all but eliminated the chances of dying or being permanently disabled from polio, smallpox, strep throat, and related illnesses that are nothing more than minor problems in today’s world.

A survey conducted by physicians and researchers from the Department of Clinical Sciences at the University of Texas, the Dallas-based Comprehensive Cancer Center, and the Department of Internal Medicine at the same university has indicated the general likelihood of people who have already been diagnosed with cancer once before and beat the disease involuntarily succumbing to such a diagnosis again.

The meta-analysis conducted found that, of roughly 741,000 individuals recently diagnosed with cancer, about 25 percent of people older than 64 years of age had experienced cancer before, whereas only 11 percent of individuals younger than 65 years of age experienced the same condition.

Further, depending on the particular type of cancer patients had experienced in the past, the prevalence of past cancer rates ranged from only 4 percent, all the way up to 37 percent, for more pervasive strains, and areas of the body affected that are generally harder to cure.

The aforementioned study was conducted across the Surveillance, Epidemiology, and End Results program – often called the SEER program – and contained sources of cancer related information in clinical settings from such registries dating from as far back as 1975, to as recently as 2013.

Arguably the most positive finding of the study is that survival rates are improving, and physicians are collectively learning more about the treatment of the disease.

Eric Lefkofsky is a Co-founder of Tempus, a technological organization that is currently building a digital library of information directly related to molecular biological data, as well as clinical performance information.

Mr. Lefkossky began his career at the University of Michigan, earning both a bachelor’s and juris doctorate at the school. His entrepreneurial spirit originally led him to sell carpet during school. After graduation, he founded an apparel company  the rest is history.

Visit More Click Here